PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $126,018 | -36.1% | 15,092 | +1.8% | 0.00% | -33.3% |
| Q2 2023 | $197,173 | +20.5% | 14,825 | +4.9% | 0.00% | +50.0% |
| Q1 2023 | $163,683 | +55.1% | 14,135 | +9.5% | 0.00% | 0.0% |
| Q4 2022 | $105,563 | +42.7% | 12,905 | +1.3% | 0.00% | +100.0% |
| Q3 2022 | $74,000 | +37.0% | 12,742 | +4.4% | 0.00% | 0.0% |
| Q2 2022 | $54,000 | -76.8% | 12,210 | +33.7% | 0.00% | -75.0% |
| Q3 2021 | $233,000 | -37.4% | 9,131 | -14.2% | 0.00% | -42.9% |
| Q2 2021 | $372,000 | – | 10,648 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |